Genetic Technologies Provides Update on its COVID-19 Disease Severity Risk Test and Expansion into Germline Testing
News Category Global Banking & Finance Reviews Genetic Technologies Provides Update on its COVID-19 Disease Severity Risk Test and Expansion into Germline Testing Genetic Technologies Provides Update on its COVID-19 Disease Severity Risk Test and Expansion into Germline Testing MELBOURNE, Australia, Jan. 21, 2021 — Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”), provides the following update to the market on further development on the COVID-...
United States United Kingdom Stephanie Ottens Laboratory Implementation Medicaid Services Clinical Laboratory Improvement Amendments Genetic Technologies Limited
Source: globalbankingandfinance.com